retatrutide type 2 diabetes phase 2 trial results 2024 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide hits 28% weight loss

An 8-hour eating window becomes 6, then 4, then 2

For example, branched-chain amino acids (BCAAs) promote inflammation-related metabolic programs through transporters and mechanistic target of mTORC1 (mTORC1) signaling, whereas under conditions of amino acid deprivation or energetic stress, starvation sensing mediated by GCN2 can restrict inflammasome activation and IL-1 production, causing supply and restriction to generate opposite immune outputs at different thresholds ( In addition, one-carbon metabolism and redox homeostasis also constitute important regulatory layers of macrophage polarization

Menopause timing is heavily genetic

For most, it is: Mild Temporary Fully reversible Hair usually returns to normal density once weight stabilises and nutrition improves